/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-09-16 08:10:032021-09-16 08:10:03AM-Pharma Appoints Lars Boesgaard as Chief Financial Officer and Establishes U.S. Affiliate AM-Pharma Inc.
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-09-08 08:13:472021-09-08 08:13:47AM-Pharma and Kyowa Kirin Sign Exclusive License Agreement for Commercialization of Ilofotase Alfa in Japan
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-07-06 08:30:402021-07-09 08:40:25AM-Pharma Appoints Mark Altmeyer as Chairman of its Supervisory Board
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-07-01 12:44:002021-07-01 12:45:28AM-Pharma Enrolls First Patient in Japan for Ongoing Phase III SA-AKI Pivotal REVIVAL Trial
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-01-07 10:01:062021-03-02 08:43:18AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2018-10-24 16:32:372021-04-22 13:56:24Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2016-12-22 16:50:262021-01-07 12:21:36Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2016-10-17 16:55:362021-01-07 12:21:42Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2016-09-27 16:53:262021-01-07 12:21:46Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2016-09-22 17:06:502021-01-07 12:21:53Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2016-05-04 16:58:542021-01-07 12:21:59Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Google Analytics Cookies
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them: